CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 28, 2023 · earnings

AKBA earnings: a positive outcome, +20.0%

On August 28, 2023, Akebia Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +20.0% in the window around the event. It had already run -27.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.15
1d before
$1.38
Event day
$1.54
1d after
$1.33
5d after

Pre-catalyst setup

-27.2%
30-day run-up
9553%
30-day volatility
1.2×
volume spike